Yonhap Infomax NewsSep 22, 2025
D&D Pharmatech shares hit the daily upper limit after news that partner Metsera is in talks for a $7.3 billion acquisition by Pfizer, boosting market optimism.
#YonhapInfomax #DDPharmatech #Metsera #Pfizer #ObesityTreatment #MASHMarketGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=82823
D&D Pharmatech Shares Surge to Daily Limit on Expectations of Partner Metsera’s Acquisition

D&D Pharmatech shares hit the daily upper limit after news that partner Metsera is in talks for a $7.3 billion acquisition by Pfizer, boosting market optimism.

Yonhap Infomax